Detection of minimal residual disease in leukemias: a critical approach.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Nouvelle revue francaise d'hematologie

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 2190175
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Detection of two alternative bcr/abl mRNA junctions and minimal residual disease in Philadelphia chromosome positive chronic myelogenous leukemia by polymerase chain reaction.

  1989cited by this paper
• In vitro amplification of T cell gamma gene rearrangements: a new tool for the assessment of minimal residual disease in acute lymphoblastic leukemias.

  1989cited by this paper
• Acute myeloid leukemia: analysis of ras gene mutations and clonality defined by polymorphic X-linked loci.

  1989cited by this paper
• Polymerase chain reaction for detection of residual leukaemia.

  1989cited by this paper
• The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases.

  1989cited by this paper
• Common acute lymphocytic leukemia antigen is identical to neutral endopeptidase

  1988cited by this paper
• Thermostable DNA polymerase chain amplification of t(14;18) chromosome breakpoints and detection of minimal residual disease.

  1988cited by this paper
• Analysis of RAS gene mutations in acute myeloid leukemia by polymerase chain reaction and oligonucleotide probes.

  1988cited by this paper
• Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro.

  1988cited by this paper
• Mutations in N-ras predominate in acute myeloid leukemia.

  1987cited by this paper
• Gene rearrangements as markers of clonal variation and minimal residual disease in acute lymphoblastic leukemia.

  1987cited by this paper
• Human T cell gamma genes are frequently rearranged in B-lineage acute lymphoblastic leukemias but not in chronic B cell proliferations

  1987cited by this paper
• Use of a liquid cell culture assay to quantify the elimination of Burkitt lymphoma cells from the bone marrow.

  1987cited by this paper
• Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification.

  1987cited by this paper
• Shifts in blast cell phenotype and karyotype at relapse of childhood lymphoblastic leukemia.

  1986cited by this paper
• Immunologic classification of leukemia and lymphoma.

  1986cited by this paper
• Detection of residual acute lymphoblastic leukemia cells in cultures of bone marrow obtained during remission.

  1986cited by this paper
• Human T-cell gamma genes contain N segments and have marked junctional variability.

  1986cited by this paper
• Immunoglobulin gene rearrangements in remission bone marrow specimens from patients with acute lymphoblastic leukemia.

  1986cited by this paper
• Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

  1985cited by this paper
• Detection of minimal residual disease in acute leukemia: possibilities and limitations.

  1985cited by this paper
• B cell origin of non-T cell acute lymphoblastic leukemia. A model for discrete stages of neoplastic and normal pre-B cell differentiation.

  1984cited by this paper
• Stages of renal ontogenesis identified by monoclonal antibodies reactive with lymphohemopoietic differentiation antigens

  1983cited by this paper
• Immunological monitoring of residual disease in treated thymic acute lymphoblastic leukaemia.

  1981cited by this paper
• Acute lymphoblastic leukaemia associated antigen. III ALterations in expression during treatment and in relapse.

  1980cited by this paper
• Acute lymphoblastic leukaemia associated antigen. IV. Expression on non-leukaemic 'lymphoid' cells.

  1980cited by this paper

• Monoclonal antibodies in the detection and treatment of micrometastatic or minimal residual disease; an overview

  2018cites this paper
• marrow transplant for chronic myelogenous leukemia detected by the polymerase chain reaction after allogeneic bone Prognostic significance of Philadelphia chromosome-positive cells

  2011cites this paper
• Detection and its clinical value of minimal residual diseases in acute promyelocytic leukemia

  2002cites this paper
• [Acute lymphoblastic leukemia in children. Progress in life expectancy].

  1997cites this paper
• Sensitivity of PCR in detecting monoclonal B cell proliferations.

  1993cites this paper
• Prognostic significance of Philadelphia chromosome-positive cells detected by the polymerase chain reaction after allogeneic bone marrow transplant for chronic myelogenous leukemia.

  1992cites this paper